ВОСТОЧНО ЗАПАДНЫЙ МЕДИЦИНСКИЙ ИНСТИТУТ LLC
Este Oeste Inctitucion medical
美国中西医学研究院
Integrative and Acupuncture &Traditional Chinese Medicine for Cancer and Other Diseases
整合中西医学治疗癌和疑难病y.
Dr. Hou was present on the conference about Cancer RESEARCHERS and CAM Practitioners: Fostering Collaborations; Advancing the Science October 22-23, 2007 Bethesda, Maryland U.S. U.S. Department of Health and Human Services,NIH, NCI, His abstract is Cancer: Using an Integrated Approach Combing Western Medicine with Traditional Chinese Medicin.
Dr.Hou was present on the conferrence of Shanghai International Symposium: Integrative Oncology Theory, Research and Practice as below April 25-26, 2008 : his abstract is Integrated TCM and Western Medicine (ICWM) System for Cancer.
Dr.Hou was in SIO with Cancer Specialists, Shanghai,
China 2008
Dr.Hou was with Scientifics in conference of Cancer CAM in NIH, USA, 2007
Dr.Hou And His Poster With Dr. Jeffrey D.White
MD who is a Director, NCI Office of Cancer CAM
were in NIH,USA 2007
Dr.Hou and His poster Joined conference by Society
for integrate Oncology in Shanghai, China 2008
Dr. Eric A. Scheinbart, M.D. and Dr. Robert Bregman Ph.D.
2008
Dr.Jan and Dr.Hou work in EWMI
1998 Dr.Hou worked in the National Square that frone of White House .
Dr. Liping Yu, Ph.D MD (China) Assistant Professor Dr. Yu obtained his MD degree and MS in Biochemistry at Nanjing Medical University in China and had his Post-Doc studies in late 1980s and early 1990s at University of Wisconsin Medical School and Harvard University Medical School. He currently is a director of clinical immunology laboratory in Barbara Davis Center in the medical school of Colorado University for Childhood Diabetes which is also current NIH/NIDDK.
Designated North America Autoantibody/HLA Core laboratory. His major interests are focused on humoral autoimmune responses and HLA genetics in Type 1 Diabetes. Islet autoantibodies (currently known to insulin, GAD65, IA-2, and ZnT8) usually appear years before clinical onset of type 1
Diabetes, therefore they are very important markers for islet autoimmunity and play an essential role in prediction, prevention, and clinical practice for diagnosis and treatment for type 1 diabetes.HLA is a well know major susceptible gene marker for type 1 diabetes. With early detection of islet autoantibodies and HLA genetic analysis, it will help to study natural history of the disease and to try understanding underlying mechanism of interaction between environmental aspects and immune system/genetics which will be important for the study of etiology of type 1 diabetes. Dr. Yu himself developed and set up all these autoantibody assays in the current laboratory and recently he has developed a new assay method for these autoantibody assays demonstrated more sensitive and more disease specific which has been patented through university
tech-transfer office and it will be used as a pilot study in NIH/NIDDK leaded national/international type 1 diabetes clinical trials for autoantibody screening. Dr. Yu also has studies on other related autoimmune diseases like Celiac disease through transglutaminase autoantibody study and Addison’s disease through 21-Hydroxilase autoantibody study. Dr.Yu does consulting about integrative east and west medicine for dibetis with Dr.Hou in EWMI now.
Fill out the form below and get full access to classified materials:
Copyright © 2009. East-West Medical Inctitute.
https://www.eastwestmedicalinstitute.us All rights reserved.
(720) 937-3979
To whom will be concern:
I did a website of Dr.Zhongping HOU'S East West Medical Institute LLC that included to made a website's photo for myself.
Web design Se Kim - RBS Real Business Studio
01/03/2019
Cancer, Cancer and Obstinate Diseases, лечение рака, лечение трудноизлечимых болезней,
EAST WEST MEDICAL INSTITUTE, ВОСТОЧНО ЗАПАДНЫЙ МЕДИЦИНСКИЙ ИНСТИТУТ, Este Oeste Inctitucion medical
美国中西医学研究院, Traditional Chinese Medicine, Acupuncture practices,Acupuncture practices in Colorado USA,